Tuesday, 21 May 2019

Lupin launches Tadalafil Tablets USP

02 April 2019 | News

It is the generic equivalent of Eli Lilly and Company’s Cialis Tablets

Lupin has announced the launch of Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, is the generic equivalent of Eli Lilly and Company’s Cialis Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. It is indicated for the treatment of:

  • erectile dysfunction (ED)
  • the signs and symptoms of benign prostatic hyperplasia (BPH)
  • ED and the signs and symptoms of BPH (ED/BPH)

Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg (RLD: Cialis) had annual sales of approximately USD 1780 million in the US (IQVIA MAT December 2018).

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account